Print

pSivida Corp (PSDV) CEO to Present at 15th Annual BioCEO & Investor Conference February 12  
2/4/2013 9:51:38 AM

pSivida Corp. (NASDAQ:PSDV)(ASX:PVA), an emerging specialty pharmaceutical company and leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its President and CEO, Dr. Paul Ashton, will present at the 15th Annual BioCEO & Investor Conference, being held at the Waldorf-Astoria Hotel in New York, Monday and Tuesday, February 11 and 12.
//-->